|

TC-D101 CAR-T Clinical Trials

1 actively recruiting trial

Also known as: Cyclophosphamide, Fludarabine

Pipeline

Early 1: 1

Top Sponsors

  • TCRCure Biopharma Ltd.1

Indications

  • CAR T Cell Therapy1
  • Small Cell Lung Cancer (SCLC)1
  • Lung Cancer1
  • Cancer1

Other1 trial

TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.